Get started
JetEquities

CytoSorbents Awarded $2,897,172 Phase III STTR Contract to Advan

Long
Cytosorbents Corporation (NASDAQ:CTSO)  
JetEquities  
NASDAQ:CTSO   Cytosorbents Corporation
Beyond Technical Analysis
2
0
beyondta
CTSO: CytoSorbents Corporation
2020-06-09 07:08:00
CytoSorbents Awarded $2,897,172 Phase III STTR Contract to Advance HemoDefend-BGA Plasma and Whole Blood Filter to Clinical Trials
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.